Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $948K | ﹤0.01% |
+5,288
| New | +$901K |
|
3352
Business First Bancshares
BFST
$1.04B
| $947K | ﹤0.01% |
40,119
-13,463
| -25% | -$333K |
|
3353
Greene County Bancorp
GCBC
$570M
| $946K | ﹤0.01% |
41,868
-320
| -0.8% | -$7.68K |
|
3354
CALL
Q2 Holdings
QTWO
$3.8B
| $941K | ﹤0.01% |
13,000
| – | – |
|
|
BFS
3355
Saul Centers
BFS
$836M
| $941K | ﹤0.01% |
29,521
-16,634
| -36% | -$549K |
|
|
NFBK
3356
DELISTED
Northfield Bancorp
NFBK
| $940K | ﹤0.01% |
79,631
-13,964
| -15% | -$160K |
|
3357
CEVA Inc
CEVA
$910M
| $938K | ﹤0.01% |
35,514
-10,049
| -22% | -$234K |
|
3358
F&G Annuities & Life
FG
$3.79B
| $938K | ﹤0.01% |
29,981
-9,754
| -25% | -$322K |
|
3359
CALL
Brown-Forman Class B
BF.B
$13.2B
| $937K | ﹤0.01% |
+34,600
| New | +$1M |
|
|
KRMN
3360
Karman Holdings
KRMN
$6.38B
| $936K | ﹤0.01% |
12,964
+273
| +2% | +$15K |
|
3361
NB Bancorp
NBBK
$1.01B
| $933K | ﹤0.01% |
52,878
-29,024
| -35% | -$532K |
|
3362
Eagle Bancorp
EGBN
$846M
| $932K | ﹤0.01% |
46,109
-31,131
| -40% | -$603K |
|
3363
Stagwell
STGW
$2.07B
| $930K | ﹤0.01% |
165,237
-55,823
| -25% | -$296K |
|
3364
Luxfer Holdings
LXFR
$456M
| $930K | ﹤0.01% |
66,892
-7,226
| -10% | -$92.8K |
|
|
SRTA
3365
Strata Critical Medical Inc
SRTA
$434M
| $930K | ﹤0.01% |
183,754
-15,704
| -8% | -$69.4K |
|
|
GOOD
3366
Gladstone Commercial Corp
GOOD
$605M
| $925K | ﹤0.01% |
75,120
-12,740
| -15% | -$170K |
|
3367
Levi Strauss
LEVI
$9.44B
| $922K | ﹤0.01% |
39,591
-443,215
| -92% | -$9.42M |
|
3368
XP
XP
$8.81B
| $922K | ﹤0.01% |
49,051
-44,857
| -48% | -$804K |
|
3369
Liquidity Services
LQDT
$1.22B
| $913K | ﹤0.01% |
33,300
-12,773
| -28% | -$329K |
|
3370
AerSale
ASLE
$293M
| $912K | ﹤0.01% |
111,348
-7,421
| -6% | -$55.9K |
|
3371
Hippo Holdings
HIPO
$830M
| $911K | ﹤0.01% |
25,199
-6,315
| -20% | -$196K |
|
3372
Opko Health
OPK
$985M
| $911K | ﹤0.01% |
587,753
-76,654
| -12% | -$105K |
|
3373
Tredegar Corp
TG
$265M
| $910K | ﹤0.01% |
113,373
-6,792
| -6% | -$56K |
|
|
MLNK
3374
DELISTED
MeridianLink
MLNK
| $910K | ﹤0.01% |
45,676
-16,385
| -26% | -$301K |
|
3375
Liberty Media Series A
FWONA
$22.5B
| $908K | ﹤0.01% |
9,535
+3,281
| +52% | +$300K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.